16191131

Source:http://linkedlifedata.com/resource/pubmed/id/16191131

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0033080, umls-concept:C0205191, umls-concept:C1257954, umls-concept:C1521941, umls-concept:C1548788, umls-concept:C2741652
pubmed:issue	10
pubmed:dateCreated	2005-9-29
pubmed:abstractText	To describe the use of coxibs outside of licensed indications and recommended dosing ranges including rofecoxib 50 mg, valdecoxib 20 to 40 mg, and celecoxib 400 mg.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/16191131-10471456, http://linkedlifedata.com/resource/pubmed/commentcorrection/16191131-10566565, http://linkedlifedata.com/resource/pubmed/commentcorrection/16191131-10580457, http://linkedlifedata.com/resource/pubmed/commentcorrection/16191131-11087881, http://linkedlifedata.com/resource/pubmed/commentcorrection/16191131-11509060, http://linkedlifedata.com/resource/pubmed/commentcorrection/16191131-12117397, http://linkedlifedata.com/resource/pubmed/commentcorrection/16191131-12383990, http://linkedlifedata.com/resource/pubmed/commentcorrection/16191131-12416789, http://linkedlifedata.com/resource/pubmed/commentcorrection/16191131-12493255, http://linkedlifedata.com/resource/pubmed/commentcorrection/16191131-12830070, http://linkedlifedata.com/resource/pubmed/commentcorrection/16191131-15096449, http://linkedlifedata.com/resource/pubmed/commentcorrection/16191131-15470192, http://linkedlifedata.com/resource/pubmed/commentcorrection/16191131-15470193, http://linkedlifedata.com/resource/pubmed/commentcorrection/16191131-3261560, http://linkedlifedata.com/resource/pubmed/commentcorrection/16191131-768652, http://linkedlifedata.com/resource/pubmed/commentcorrection/16191131-9718051
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8605834
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents..., http://linkedlifedata.com/resource/pubmed/chemical/Cyclooxygenase Inhibitors
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	1525-1497
pubmed:author	pubmed-author:ArbogastPatrick GPG, pubmed-author:GriffinMarie RMR, pubmed-author:MitchelEdward FEFJr, pubmed-author:RoumieChristianne LCL
pubmed:issnType	Electronic
pubmed:volume	20
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	879-83
pubmed:dateRevised	2009-11-18
pubmed:meshHeading	pubmed-meshheading:16191131-Anti-Inflammatory Agents, Non-Steroidal, pubmed-meshheading:16191131-Chronic Disease, pubmed-meshheading:16191131-Cyclooxygenase Inhibitors, pubmed-meshheading:16191131-Drug Prescriptions, pubmed-meshheading:16191131-Female, pubmed-meshheading:16191131-Humans, pubmed-meshheading:16191131-Male, pubmed-meshheading:16191131-Medicaid, pubmed-meshheading:16191131-Osteoarthritis, pubmed-meshheading:16191131-Reproducibility of Results, pubmed-meshheading:16191131-Tennessee, pubmed-meshheading:16191131-United States
pubmed:year	2005
pubmed:articleTitle	Prescriptions for chronic high-dose cyclooxygenase-2 inhibitors are often inappropriate and potentially dangerous.
pubmed:affiliation	Veterans Administration, Tennessee Valley Healthcare System, Tennessee Valley Geriatric Research Education Clinical Center (GRECC), Nashville, Tenn 37212, USA. christianne.roumie@vanderbilt.edu
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't